If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPanthera Res. Regulatory News (PAT)

Share Price Information for Panthera Res. (PAT)

Share Price is delayed by 15 minutes
Get Live Data
20.95    0.50 (2.44%)
Bid:
20.40
Ask:
21.50
Spread: 1.10 (5.392%)
Market Cap: £54.45m
PAT Live PriceLast checked at - London Stock Exchange

Intraday Panthera Res. Share Chart

Issue of Equity - Warrant Conversion and Fees

3 Nov 2025 11:02

RNS Number : 9249F
Panthera Resources PLC
03 November 2025
 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the UK Market Abuse Regulation

3 November 2025

 

Panthera Resources Plc

("Panthera" or the "Company")

 

Issue of Equity - Warrant Conversion and In Lieu of Fees

 

Gold exploration and development company Panthera Resources Plc (AIM: PAT), with assets in West Africa and India, announces the issue of 910,486 new ordinary shares of 1p each in the capital of the Company (the "Ordinary Shares"), at an average issue price of 7.98 pence per new Ordinary Share (the "Issue Price") to settle certain director fees and warrant conversion.

 

Director Fees

 

The Company has agreed to issue 225,192 new Ordinary Shares in order to satisfy the Company's non-executive directors' accrued fees for the period between 1 April 2025 to 30 September 2025 (together the "Fee Shares").

 

The issue of equity in order to satisfy accrued fees has been done in previous years in relation to the Company's non-executive directors. In this regard, the issue of the Fee Shares reduces the Company's cash expenditures and further aligns the interests of the Company's board of directors with the Company's shareholders. The Fee Shares were priced at the 30-day volume-weighted average price in the month preceding each respective fee period. Further details of the Fee Shares are as follows:

 

Name (Title)

(Description)

PRICE PER Fee SHARE

NUMBER OF Fee SHARES ISSUED

beneficial SHARES HELD AFTER ISSUE

% HOLDING POST ISSUE

MICHAEL HIGGINS (Chairman)

50% fees Apr-Jun 2025 

£0.11840 

36,950 

50% fees Jul-Sep 2025  

£0.12030 

36,369 

Total

 

73,319 

9,744,273 

3.91% 

 

 

David Stein (Director)

 

 

50% fees Apr-Jun 2025 

£0.11840 

21,114 

 

50% fees Jul-Sep 2025  

£0.12030 

20,782 

 

Total 

41,896 

842,843 

0.34%

 

 

 

 

Catherine Apthorpe (Director)

 

 

50% fees Apr-Jun 2025 

£0.11840 

21,114 

 

50% fees Jul-Sep 2025  

£0.12030 

20,782 

 

Total 

41,896 

802,327 

0.32%

 

 

 

 

Timothy Hargreaves (Director)

 

 

50% fees Apr-Jun 2025 

£0.11840 

34,310 

 

50% fees Jul-Sep 2025  

£0.12030 

33,771 

 

Total 

68,081 

2,957,451 

1.19%

 

 

 

 

Grand Total

 

225,192

 

 

 

Warrant Conversion

 

The Company has agreed to issue 685,294 new Ordinary Shares to settle warrant conversion requests at an exercise price of 6.68 pence per warrant (the "Warrant Conversion"). The Warrant Conversion raises £45,777.64 for the Company.

 

As part of the abovementioned Warrant Conversion, Mark Cranny, the non-board Chief Financial Officer of the Company, has requested to convert warrants over 450,000 new Ordinary Shares at an exercise price of 6.68 pence per warrant. Following Admission (as defined below), Mark Cranny will hold 1,500,000 Ordinary Shares.

 

Application for Admission

 

Application has been made for the 910,486 new Ordinary Shares to be admitted to trading on AIM, which is expected to take effect on or around 6 November 2025 ("Admission").

 

Following Admission, the Company's issued share capital will comprise 249,413,039 Ordinary Shares. The Company does not hold any Ordinary Shares in treasury. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Contacts

 

Panthera Resources PLC

Mark Bolton (Managing Director) +61 411 220 942

contact@pantheraresources.com

 

Allenby Capital Limited (Nominated Adviser & Joint Broker) +44 (0) 20 3328 5656

John Depasquale / Vivek Bhardwaj (Corporate Finance)

Kelly Gardiner (Sales & Corporate Broking)

 

VSA Capital Limited (Joint Broker) +44 (0) 20 3005 5000

Andrew Monk / Andrew Raca

 

Novum Securities Limited (Joint Broker) +44 (0) 20 7399 9400

Colin Rowbury

 

Subscribe for Regular Updates

 

Follow the Company on Twitter at @PantheraPLC

 

For more information and to subscribe to updates visit: pantheraresources.com

 

Forward-looking Statements

This news release contains forward-looking statements that are based on the Company's current expectations and estimates. Forward-looking statements are frequently characterised by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate", "suggest", "indicate" and other similar words or statements that certain events or conditions "may" or "will" occur. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual events or results to differ materially from estimated or anticipated events or results implied or expressed in such forward-looking statements. Such factors include, among others: the actual results of current exploration activities; conclusions of economic evaluations; changes in project parameters as plans continue to be refined; possible variations in ore grade or recovery rates; accidents, labour disputes and other risks of the mining industry; delays in obtaining governmental approvals or financing; and fluctuations in metal prices. There may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. Any forward-looking statement speaks only as of the date on which it is made and, except as may be required by applicable securities laws, the Company disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or results or otherwise. Forward-looking statements are not guarantees of future performance and accordingly, undue reliance should not be put on such statements due to the inherent uncertainty therein.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:

 

1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

PDMRs:

Michael Higgins

Non-Executive Chairman

Catherine Apthorpe

Non-Executive Director

David Stein

Non-Executive Director

Timothy Hargreaves

Non-Executive Director

2. 

Reason for the Notification

a)

Position/status

See 1a) above

b)

Initial notification/Amendment

Initial Notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Panthera Resources Plc

 

b)

LEI

213800IB98EG6736XN82

 

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 1p each in Panthera Resources Plc

 

Identification code

ISIN: GB00BD2B4L05

b)

Nature of the transaction

Fee Shares

 

c)

Price(s) and volume(s)

Name

Price(s)

Volume(s)

Michael Higgins

£0.11934

73,319

Catherine Apthorpe

£0.11934

41,896

David Stein

£0.11934

41,896

Timothy Hargreaves

£0.11934

68,081

d)

Aggregated information:

- Aggregated volume

225,192

- Price

N/A - see above.

e)

Date of the transaction

3 November 2025

f)

Place of the transaction

Outside a trading venue

 

 

1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mark Cranny

2. 

Reason for the Notification

a)

Position/status

Non-Board Chief Financial Officer

b)

Initial notification/Amendment

Initial Notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Panthera Resources Plc

 

b)

LEI

213800IB98EG6736XN82

 

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 1p each in Panthera Resources Plc

 

Identification code

ISIN: GB00BD2B4L05

b)

Nature of the transaction

Issue of new Ordinary Shares following Warrant Conversion

 

c)

Price(s) and volume(s)

450,000 at 6.68 pence per warrant

d)

Aggregated information:

- Aggregated volume

N/A

- Price

N/A

e)

Date of the transaction

3 November 2025

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFSFFFDEISESF
Date   Source Headline
1st Jul 20267:00 amRNSConversion of Options
30th Jun 20265:15 pmRNSTotal Voting Rights
11th Jun 20267:08 amRNSConversion of Options
3rd Jun 20267:00 amRNS-ROnline Investor Webinar
29th May 20265:15 pmRNSTotal Voting Rights
21st May 20267:00 amRNSConversion of Options
6th May 20267:00 amRNSConversion of Options
30th Apr 20265:00 pmRNSTotal Voting Rights
14th Apr 20267:09 amRNSConversion of Options
9th Apr 20262:31 pmRNSIssue of Equity – In Lieu of Director Fees
2nd Mar 20267:00 amRNSArbitration Update
19th Jan 20267:00 amRNSBido Drilling Results
31st Dec 202512:45 pmRNSTotal Voting Rights
31st Dec 202512:45 pmRNSTotal Voting Rights
29th Dec 20257:00 amRNSHalf-year Financial Report
29th Dec 20257:00 amRNSHalf-year Financial Report
11th Dec 20257:00 amRNSWarrant Conversion
3rd Dec 20257:00 amRNSWarrant Conversion
1st Dec 20257:00 amRNSTotal Voting Rights
25th Nov 20258:59 amRNSWarrant Conversion
21st Nov 20257:00 amRNSKalaka Metallurgical Study Results
20th Nov 20252:00 pmRNSWarrant Conversion
17th Nov 20257:00 amRNSOTCQB Approval
12th Nov 20257:00 amRNSOTC Application
3rd Nov 202511:02 amRNSIssue of Equity - Warrant Conversion and Fees
31st Oct 20255:05 pmRNSTotal Voting Rights
29th Oct 20257:00 amRNSArbitration Update
16th Oct 20255:05 pmRNSWarrant Conversion
9th Oct 202510:31 amRNSWarrant Conversion
8th Oct 20257:00 amRNSArbitration Financing Facility Update
3rd Oct 202511:30 amRNSResult of AGM
29th Sep 20257:00 amRNSChange of Registered Office
18th Sep 20257:00 amRNSArbitration Update
29th Aug 20255:00 pmRNSTotal Voting Rights
27th Aug 20257:58 amRNS2025 Annual Financial Report
8th Aug 20257:00 amRNSOption Conversion
4th Aug 20257:00 amRNSCommencement of Cascades Feasibility Study
25th Jul 20257:32 amRNSWarrant Conversion
18th Jul 20257:00 amRNSBido Drilling
19th May 20257:00 amRNSUS$1.58 billion Claim for Damages
30th Apr 20255:00 pmRNSTotal Voting Rights
16th Apr 20253:54 pmRNSIssue of Equity - Warrant Conversion and Fees
31st Mar 20255:00 pmRNSTotal Voting Rights
27th Mar 20257:00 amRNSIssue of Equity - Conversion of Options
20th Mar 202510:37 amRNSWarrant Exercise
7th Mar 20255:35 pmRNSNotification of Major Holding
6th Mar 20254:45 pmRNSUpdate on Issue of Equity Fundraising
28th Feb 20255:32 pmRNSNotification of Major Holding
25th Feb 20257:47 amRNSResult of Placing and Subscription
24th Feb 20255:04 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.